Aptose Biosciences Inc

General ticker "APTO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.6M

Aptose Biosciences Inc does not follow the US Stock Market performance with the rate: -40.8%.

Estimated limits based on current volatility of 11.7%: low 0.24$, high 0.30$

Factors to consider:

  • Current price 84.0% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.55$, 4.15$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.81$, 2.46$]

Financial Metrics affecting the APTO estimates:

  • Negative: Non-GAAP EPS, $ of -7.72 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -73.03 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Net income

Similar symbols

Short-term APTO quotes

Long-term APTO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.09MM $0.78MM $0.00MM
Operating Expenses $65.45MM $42.60MM $52.36MM
Operating Income $-65.35MM $-41.82MM $-52.36MM
Non-Operating Income $0.00MM $0.00MM $1.15MM
R&D Expense $45.98MM $28.09MM $36.77MM
Income(Loss) $-65.35MM $-41.82MM $-51.21MM
Profit(Loss) $-65.35MM $-41.82MM $-51.21MM
Stockholders Equity $74.24MM $37.74MM $-2.90MM
Assets $82.53MM $51.03MM $12.99MM
Operating Cash Flow $-43.30MM $-32.32MM $-44.59MM
Capital expenditure $0.21MM $0.02MM $0.03MM
Investing Cash Flow $-35.21MM $30.07MM $9.96MM
Financing Cash Flow $0.23MM $0.12MM $6.91MM
Earnings Per Share* $-10.99 $-6.67 $-7.58

* EPS are Split Adjusted, recent splits may be reflected with a delay.